IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice

This retrospective study evaluated 66 patients diagnosed with relapsed and/or refractory mantle cell lymphoma (R/R MCL) treated with ibrutinib in Spain in routine clinical practice. At diagnosis, patients had a median age of 64.5 years, 63.6% presented with intermediate/high sMIPI (simplified progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Sancho, Juan-Manuel, Marín-Niebla, Ana, Fernández, Silvia, Capote, Francisco-Javier, Cañigral, Carolina, Grande, Carlos, Donato, Eva, Zeberio, Izaskun, Puerta, Jose-Manuel, Rivas, Alfredo, Pérez-Ceballos, Elena, Vale, Ana, Martín García-Sancho, Alejandro, Salar, Antonio, González-Barca, Eva, Teruel, Anabel, Pastoriza, Carmen, Conde-Royo, Diego, Sánchez-García, Joaquín, Barrenetxea, Cristina, Arranz, Reyes, Hernández-Rivas, José-Ángel, Ramírez, María-José, Jiménez, Aroa, Rubio-Azpeitia, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392694/
https://www.ncbi.nlm.nih.gov/pubmed/35551632
http://dx.doi.org/10.1007/s12185-022-03367-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392694/
https://www.ncbi.nlm.nih.gov/pubmed/35551632
http://dx.doi.org/10.1007/s12185-022-03367-z

Ejemplares similares